The harm-reduction approach to prostate cancer screening

Andrew Vickers, PhD, of the Memorial Sloan Kettering Cancer Center, New York City, NY, speaks at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA, on the factors which make PSA screening useful as oppose to harmful to the patient.